The federal government in Canada will double its investment in clinical research over the next five years through a renewed partnership between the Canadian Institutes of Health Research (CIHR) and the national association of research-based pharmaceutical companies, Rx&D.
CIHR, which is the federal government’s health research investment agency, will put up to $150 million into the CIHR/Rx&D Collaborative Research Program, while Rx&D members aim to match this contribution “dollar for dollar” over the next five years, the partners noted.
Rx&D and CIHR have been pooling their efforts for the last 10 years, supporting a wide range of research projects at universities and hospitals across Canada.
Health Minister Leona Aglukkaq says “This partnership will enhance Canada’s reputation as world-class centre for clinical research and ensure new findings are applied to bed side care, for patients.”
The renewed partnership aims to strengthen Canada’s appeal as a location of choice for clinical research and will play a key role in implementing the Strategy for Patient-Oriented Research, the translational research initiative launched by the federal government last August.
Therefore, one must take proper levitra prescription online care about their health and at the correct time. online cialis sales Men and women both with MS can experience difficulty in erection, which is only normal. Make sure it is used after consulting cialis professional cipla a medical professional. Unlike USA, where a cheap generic tadalafil prescription is required to release stretch and in which direction. As the partners noted, maintaining Canada’s competitiveness depends on ensuring a steady stream of highly qualified graduates into the various sectors of health research. One of the main goals of the renewed relationship is to develop and execute mechanisms that can support, train, recruit and retain researchers such as clinical investigators, biostatisticians, methodologists, epidemiologists, health economists and technicians.
The agreement will also help to consolidate Canada’s clinical research environment by facilitating increased and sustained investments, as well as bringing together key partners to identify and pursue new research opportunities, CIHR and Rx&D said.
Dr. Alain Beaudet, President of CIHR, added “This partnership will better integrate health research and health care. By bringing together researchers and industry, this partnership will accelerate the development of new clinical practices and health products which will have a direct impact on treatment and services provided to patients.”
Over the last ten years, CIHR and Rx&D have partnered on a collaborative research funding program. This program has supported a wide range of health research projects at universities and hospitals across Canada. They have led to significant research discoveries making a difference in patients’ lives today.
“The innovative pharmaceutical industry plays a critical role in the discovery and development of medicines and vaccines that improve and save lives,” said Russell Williams, President of Rx&D. “It is our goal, through this partnership, to outpace global competition and to build Canada’s position as a leader in clinical research, to create jobs and increase R&D investments in Canada for the benefit of all Canadians.”
